•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S07987 Summary:

BILL NOS07987A
 
SAME ASNo Same As
 
SPONSORMAYER
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L; add §§4406-j & 2404-e, Pub Health L
 
Ensures continuity of care for cancer patients during insurance contract negotiations by requiring insurance coverage and treatment continue until the conclusion of care.
Go to top

S07987 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         7987--A
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                      May 15, 2025
                                       ___________
 
        Introduced  by  Sen.  MAYER  -- read twice and ordered printed, and when
          printed to be committed to the Committee  on  Insurance  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee
 
        AN ACT to amend the insurance law and the public health law, in relation
          to  ensuring  continuity  of care for cancer patients during insurance
          contract negotiations
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. This act shall be known and may be cited as the "Continuity
     2  of Cancer Care Act" or the "COCCA".
     3    §  2.  Section  3216  of  the insurance law is amended by adding a new
     4  subsection (n) to read as follows:
     5    (n) (1) For the purpose of this subsection:
     6    (A) "course of treatment" shall mean that the treatment protocol aimed
     7  at combating the insured's cancer has been administered and the  insured
     8  is  clinically  stable. Additionally, follow-up appointments/care for up
     9  to ninety days after the insured is found to be clinically stable  shall
    10  also be considered part of the insured's course of treatment.
    11    (B)  "clinical stability" shall mean ninety days have passed since the
    12  treatment has been fully administered and: (i)  the  insured  shows  the
    13  intended result from their treatment protocol without complications that
    14  would  require  ongoing management by the provider's physicians; or (ii)
    15  the insured is receiving maintenance treatment  to  control  the  cancer
    16  from reoccurring.
    17    (2)  An  insurer  shall,  where  an insured is receiving treatment for
    18  cancer at a  hospital,  doctor's  office  or  any  other  provider  that
    19  provides  oncology treatment which such insurer was covering in whole or
    20  in part and such insurer and such provider cannot come to  an  agreement
    21  during  contract negotiations, continue to cover such treatments, at the
    22  rate payable under the  prior  contract,  for  such  insured  until  the
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10785-03-5

        S. 7987--A                          2
 
     1  conclusion of such insured's entire course of treatment and the individ-
     2  ual  is  found  to  be clinically stable, provided that the rate payable
     3  under the prior contract shall be adjusted by  the  applicable  Medicare
     4  Economic  Index  minus  one percentage point applied to payment rates at
     5  the start of the next calendar year, and for  each  succeeding  calendar
     6  year,  for individuals that are continuing to receive treatment pursuant
     7  to this provision.
     8    § 3. Section 3221 of the insurance law is  amended  by  adding  a  new
     9  subsection (v) to read as follows:
    10    (v) (1) For the purpose of this subsection:
    11    (A) "course of treatment" shall mean that the treatment protocol aimed
    12  at  combating the insured's cancer has been administered and the insured
    13  is clinically stable. Additionally, follow-up appointments/care  for  up
    14  to  ninety days after the insured is found to be clinically stable shall
    15  also be considered part of the insured's course of treatment.
    16    (B) "clinical stability" shall mean ninety days have passed since  the
    17  treatment  has  been  fully  administered and: (i) the insured shows the
    18  intended result from their treatment protocol without complications that
    19  would require ongoing management by the provider's physicians;  or  (ii)
    20  the  insured  is  receiving  maintenance treatment to control the cancer
    21  from reoccurring.
    22    (2) An insurer shall, where an  insured  is  receiving  treatment  for
    23  cancer  at  a  hospital,  doctor's  office  or  any  other provider that
    24  provides oncology treatment which such insurer was covering in whole  or
    25  in  part  and such insurer and such provider cannot come to an agreement
    26  during contract negotiations, continue to cover such treatments, at  the
    27  rate  payable  under  the  prior  contract,  for  such insured until the
    28  conclusion of such insured's entire course of treatment and the individ-
    29  ual is found to be clinically stable, provided  that  the  rate  payable
    30  under  the  prior  contract shall be adjusted by the applicable Medicare
    31  Economic Index minus one percentage point applied to  payment  rates  at
    32  the  start  of  the next calendar year, and for each succeeding calendar
    33  year, for individuals that are continuing to receive treatment  pursuant
    34  to this provision.
    35    §  4.  Section  4303  of  the insurance law is amended by adding a new
    36  subsection (i) to read as follows:
    37    (i) (1) For the purpose of this subsection:
    38    (A) "course of treatment" shall mean that the treatment protocol aimed
    39  at combating the insured's cancer has been administered and the  insured
    40  is  clinically  stable. Additionally, follow-up appointments/care for up
    41  to ninety days after the insured is found to be clinically stable  shall
    42  also be considered part of the insured's course of treatment.
    43    (B)  "clinical stability" shall mean ninety days have passed since the
    44  treatment has been fully administered and: (i)  the  insured  shows  the
    45  intended result from their treatment protocol without complications that
    46  would  require  ongoing management by the provider's physicians; or (ii)
    47  the insured is receiving maintenance treatment  to  control  the  cancer
    48  from reoccurring.
    49    (2)  An  insurer  shall,  where  an insured is receiving treatment for
    50  cancer at a  hospital,  doctor's  office  or  any  other  provider  that
    51  provides  oncology treatment which such insurer was covering in whole or
    52  in part and such insurer and such provider cannot come to  an  agreement
    53  during  contract negotiations, continue to cover such treatments, at the
    54  rate payable under the previous contract, for  such  insured  until  the
    55  conclusion  of such insured's entire course of treatment and the insured
    56  is found to be clinically stable, provided that the rate  payable  under

        S. 7987--A                          3
 
     1  the prior contract shall be adjusted by the applicable Medicare Economic
     2  Index  minus  one percentage point applied to payment rates at the start
     3  of the next calendar year, and for each succeeding  calendar  year,  for
     4  individuals  that  are  continuing to receive treatment pursuant to this
     5  provision.
     6    § 5. The public health law is amended by adding a new  section  4406-j
     7  to read as follows:
     8    §  4406-j.  Continuity  of  cancer  care.  1.  For the purpose of this
     9  section:
    10    (a) "course of treatment" shall mean that the treatment protocol aimed
    11  at combating the insured's cancer has been administered and the  insured
    12  is  clinically  stable. Additionally, follow-up appointments/care for up
    13  to ninety days after the insured is found to be clinically stable  shall
    14  also be considered part of the insured's course of treatment.
    15    (b)  "clinical stability" shall mean ninety days have passed since the
    16  treatment has been fully administered and: (i)  the  insured  shows  the
    17  intended result from their treatment protocol without complications that
    18  would  require  ongoing management by the provider's physicians; or (ii)
    19  the insured is receiving maintenance treatment  to  control  the  cancer
    20  from reoccurring.
    21    2.  An organization shall, where an  insured  is  receiving  treatment
    22  for cancer at a hospital, doctor's office or  any  other  provider  that
    23  provides  oncology  treatment  which  such  organization was covering in
    24  whole or in part and  such  organization   and   such provider    cannot
    25  come  to  an  agreement  during contract negotiations, continue to cover
    26  such treatments, at the rate payable under the prior contract, for  such
    27  insured  until the conclusion of such insured's entire course of  treat-
    28  ment  and the individual is found to be clinically stable, provided that
    29  the rate payable under the prior  contract  shall  be  adjusted  by  the
    30  applicable Medicare Economic Index minus one percentage point applied to
    31  payment  rates  at  the  start  of  the next calendar year, and for each
    32  succeeding calendar year, for individuals that are continuing to receive
    33  treatment pursuant to this provision.
    34    § 6. The public health law is amended by adding a new  section  2404-e
    35  to read as follows:
    36    §  2404-e.  Cancer;  duty to continue treatment. 1. For the purpose of
    37  this section:
    38    (a) "course of treatment" shall mean that the treatment protocol aimed
    39  at combating the insured's cancer has been administered and the  insured
    40  is  clinically  stable. Additionally, follow-up appointments/care for up
    41  to ninety days after the insured is found to be clinically stable  shall
    42  also be considered part of the insured's course of treatment.
    43    (b)  "clinical stability" shall mean ninety days have passed since the
    44  treatment has been fully administered and: (i)  the  insured  shows  the
    45  intended result from their treatment protocol without complications that
    46  would  require  ongoing management by the provider's physicians; or (ii)
    47  the insured is receiving maintenance treatment  to  control  the  cancer
    48  from reoccurring.
    49    2.  Where  a  person  is receiving treatment for cancer at a hospital,
    50  doctor's office or any other provider that provides  oncology  treatment
    51  which  is  covered  by such person's insurance company and such provider
    52  and such person's insurance company cannot come to an  agreement  during
    53  contract negotiations, such person shall remain under continuous care of
    54  such provider and such person's insurance shall continue to provide such
    55  coverage  for  such  treatments,  at  the  rate  payable under the prior
    56  contract, until the conclusion of such person's entire course of  treat-

        S. 7987--A                          4
 
     1  ment and the insured is found to be clinically stable, provided that the
     2  rate  payable under the prior contract shall be adjusted by the applica-
     3  ble Medicare Economic  Index  minus  one  percentage  point  applied  to
     4  payment  rates  at  the  start  of  the next calendar year, and for each
     5  succeeding calendar year, for individuals that are continuing to receive
     6  treatment pursuant to this provision.
     7    § 7. This act shall take effect immediately.
Go to top